Leidos (NYSE:LDOS) announced a new contract to modernize the Organ Procurement and Transplant Network (OPTN), a critical system that delivers vital organ transplant information to patients, donors, ...

Leidos (LDOS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...

Focus Financial Network Inc. lowered its stake in Leidos Holdings, Inc. (NYSE:LDOS – Free Report) by 10.3% during the third quarter, according to the company in its most recent disclosure with the ...

Barclays analyst David E. Strauss maintained a Buy rating on Leidos Holdings (LDOS – Research Report) on November 1 and set a price ...

Leidos (NYSE:LDOS – Get Free Report) had its price objective lifted by investment analysts at Wells Fargo & Company from $183.00 to $230.00 in a research note issued on Wednesday, Benzinga reports.

Leidos (NYSE:LDOS) announced today a new contract to provide critical supply support for weapons systems that keep the U.S.

Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate ...